Lineage Cell Therapeutics, Inc. Common Stock (LCTX)

Sales/Maturities of Investments

$20.46M

TTM · Period ending: · USD

LCTX logo

LCTX Sales/Maturities of Investments

Latest reported$20.46M
LCTX TTM Sales/Maturities of Investments ($0.00 → $20.46M)
High-resolution chart · PNG

LCTX sales/maturities of investments history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Lineage Cell Therapeutics, Inc. Common Stock Sales/Maturities of Investments — Trailing twelve months (TTM) (USD)
Period endingSales/Maturities of Investments (USD)
20,460,000
5,965,000
2,000,000
5,000,000
9,000,000
9,018,000
7,018,000
13,851,000
15,880,000
40,194,000
63,526,000
53,693,000
47,664,000
23,332,000
0
0
0
0
0
-16,700,000
-16,486,000
-16,486,000
-11,265,000
6,095,000
19,436,000
19,436,000
14,215,000
13,555,000
0
0
0
-8,898,000
-8,898,000
-8,898,000
-8,898,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.